These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20460921)

  • 21. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.
    Kyrou I; Valsamakis G; Tsigos C
    Ann N Y Acad Sci; 2006 Nov; 1083():270-305. PubMed ID: 17148745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking the cannabinoid receptors: drug candidates and therapeutic promises.
    Muccioli GG
    Chem Biodivers; 2007 Aug; 4(8):1805-27. PubMed ID: 17712820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptors and endocannabinoids: evidence for new players.
    Mackie K; Stella N
    AAPS J; 2006 Apr; 8(2):E298-306. PubMed ID: 16796380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A role for the endocannabinoid system in hepatic steatosis].
    Valenzuela C; Castillo V; Ronco AM; Aguirre C; Hirsch S; Llanos M
    Rev Med Chil; 2014 Mar; 142(3):353-60. PubMed ID: 25052273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endocannabinoid system and the control of glucose homeostasis.
    Nogueiras R; Rohner-Jeanrenaud F; Woods SC; Tschöp MH
    J Neuroendocrinol; 2008 May; 20 Suppl 1():147-51. PubMed ID: 18426514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid receptors as therapeutic targets.
    Mackie K
    Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology of cannabinoid receptors].
    Le Fur G; Rinaldi-Carmona M; Barth F; Alexander J
    Bull Acad Natl Med; 2007; 191(4-5):933-8; discussion 938-40. PubMed ID: 18225447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
    Bátkai S; Mukhopadhyay P; Harvey-White J; Kechrid R; Pacher P; Kunos G
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1689-95. PubMed ID: 17557913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the endocannabinoid system in the development of tolerance to alcohol.
    Basavarajappa BS; Hungund BL
    Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid system and cardio-metabolic risk.
    Loh KY; Kew ST
    Med J Malaysia; 2008 Oct; 63(4):348-50; quiz 351. PubMed ID: 19385504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cannabinoids in the development of fatty liver (steatosis).
    Purohit V; Rapaka R; Shurtleff D
    AAPS J; 2010 Jun; 12(2):233-7. PubMed ID: 20204561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis.
    Bazwinsky-Wutschke I; Zipprich A; Dehghani F
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
    Basavarajappa BS; Nixon RA; Arancio O
    Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
    Pacher P; Haskó G
    Br J Pharmacol; 2008 Jan; 153(2):252-62. PubMed ID: 18026124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.